glp-1 obesity drugs updates today Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford Anti-Obesity Drug Market Size and

Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats

In May 2026, the Centers for Medicare & Medicaid Services (CMS) announced a major new effort to improve access to high-cost weight-loss medications for older Americans

From the clinical point of view symptoms were reduced in the 89 % of the patients

00:00:22 Narrator She walks through how it compares to injections, what patients need to know about administration, and when switching dosage forms makes sense, in an excerpt from our popular Pharmacy Essential Updates webinar series

Key Takeaway: Success with semaglutide is found in consistency and patience

T.UpadhyayaA.PhilpL